| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| CCCC | Exit | C4 THERAPEUTICS, INC. | $0 | – | -1,276,574 | -100.0% | -0.35% | – |
| MRUS | Exit | MERUS N.V. | $0 | – | -300,000 | -100.0% | -1.04% | – |
| CABA | Exit | CABALETTA BIO, INC | $0 | – | -486,795 | -100.0% | -1.09% | – |
| GRCL | Exit | GRACELL BIOTECHNOLOGIES INC.adrs | $0 | – | -3,038,889 | -100.0% | -1.29% | – |
| Exit | ENTRADA THERAPEUTICS INC | $0 | – | -584,955 | -100.0% | -1.36% | – | |
| IMVT | Exit | IMMUNOVANT, INC | $0 | – | -334,853 | -100.0% | -1.89% | – |
| KURA | Exit | KURA ONCOLOGY INC | $0 | – | -1,423,642 | -100.0% | -1.91% | – |
| CNTA | Exit | CENTESSA PHARMACEUTICALS PLC | $0 | – | -2,040,816 | -100.0% | -1.94% | – |
| DYN | Exit | DYNE THERAPEUTICS, INC | $0 | – | -1,650,150 | -100.0% | -2.18% | – |
| Exit | RAYZEBIO, INC. | $0 | – | -869,908 | -100.0% | -2.84% | – | |
| TARS | Exit | TARSUS PHARMACEUTICALS, INC. | $0 | – | -1,142,857 | -100.0% | -2.99% | – |
| SLN | Exit | SILENCE THERAPEUTICS PLCadrs | $0 | – | -2,104,875 | -100.0% | -3.04% | – |
| MDGL | Exit | MADRIGAL PHARMACEUTICALS INC | $0 | – | -179,917 | -100.0% | -3.87% | – |
| Exit | TYRA BIOSCIENCES INC | $0 | – | -1,989,103 | -100.0% | -4.03% | – | |
| Exit | VENTYX BIOSCIENCES, INC | $0 | – | -815,724 | -100.0% | -4.17% | – | |
| CMPS | Exit | COMPASS PATHWAYS PLCadrs | $0 | – | -3,858,000 | -100.0% | -4.20% | – |
| Exit | Icosavax, Inc. | $0 | – | -3,703,704 | -100.0% | -4.23% | – | |
| AVTE | Exit | AEROVATE THERAPEUTICS INC | $0 | – | -2,201,274 | -100.0% | -4.40% | – |
| INBX | Exit | INHIBRX,INC | $0 | – | -1,750,387 | -100.0% | -4.73% | – |
| KALV | Exit | KALVISTA PHARMACEUTICALS, INC | $0 | – | -3,395,495 | -100.0% | -4.82% | – |
| TSHA | Exit | TAYSHA GENE THERAPIES, INC. | $0 | – | -11,111,111 | -100.0% | -5.17% | – |
| SVRA | Exit | SAVARA INC. | $0 | – | -10,000,000 | -100.0% | -5.57% | – |
| Exit | AN2 Therapeutics, Inc. | $0 | – | -2,678,209 | -100.0% | -6.34% | – | |
| GERN | Exit | GERON CORP | $0 | – | -23,375,839 | -100.0% | -7.30% | – |
| COGT | Exit | COGENT BIOSCIENCES INC | $0 | – | -5,631,042 | -100.0% | -8.08% | – |
| Exit | STRUCTURE THERAPEUTICS INCadrs | $0 | – | -1,502,747 | -100.0% | -11.16% | – |
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| COGENT BIOSCIENCES INC | 8 | Q3 2023 | 15.6% |
| AEROVATE THERAPEUTICS INC | 8 | Q3 2023 | 6.5% |
| TYRA BIOSCIENCES INC | 8 | Q3 2023 | 6.2% |
| ENTRADA THERAPEUTICS INC | 8 | Q3 2023 | 5.3% |
| MERUS N.V. | 8 | Q3 2023 | 3.4% |
| IVERIC BIO INC | 7 | Q2 2023 | 24.4% |
| Geron Corporation | 7 | Q3 2023 | 12.4% |
| ACLARIS THERAPEUTICS INC | 7 | Q2 2023 | 7.9% |
| KURA ONCOLOGY INC | 7 | Q3 2023 | 9.1% |
| ALPINE IMMUNE SCIENCES INC | 7 | Q2 2023 | 7.6% |
View TCG Crossover Management, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Silence Therapeutics plc | August 19, 2022 | 6,314,625 | 5.9% |
| CymaBay Therapeutics, Inc. | November 29, 2021 | 5,905,400 | 7.0% |
| Cogent Biosciences, Inc. | November 17, 2021 | 2,716,042 | 6.8% |
| Tyra Biosciences, Inc. | September 29, 2021 | 937,500 | 2.2% |
| Viridian Therapeutics, Inc.\DE | September 29, 2021 | 1,314,000 | 8.2% |
View TCG Crossover Management, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-05-15 |
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| SC 13G | 2022-08-19 |
| 13F-HR | 2022-08-15 |
| 13F-HR | 2022-05-16 |
View TCG Crossover Management, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.